InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Van Plew Daniel P, Chief Executive Officer. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 18 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €384k. History available since 9 August 2021. The latest transaction was disclosed on 9 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Van Plew Daniel P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
2,552 shares@ US$701.511.6% of flowCommon StockSEC:0001411984-25-000007:0
3,715 shares0Common StockSEC:0001411984-25-000005:0
969 shares@ US$730.810.6% of flowCommon StockSEC:0001968202-24-000142:0
3,499 shares0Common StockSEC:0001883850-24-000049:0
439 shares@ US$937.940.4% of flowCommon StockSEC:0001968202-24-000066:0
12,250 shares@ US$372.464.0% of flowCommon StockSEC:0001968202-24-000064:0
1,108 shares@ US$843.790.8% of flowCommon StockSEC:0001883850-23-000091:0
23,125 shares@ US$381.407.6% of flowCommon StockSEC:0001968202-23-000028:0
3,798 shares0Common StockSEC:0001883850-22-000137:0
492 shares@ US$753.280.3% of flowCommon StockSEC:0001883850-22-000118:0
50,000 shares@ US$378.9817.3% of flowCommon StockSEC:0001883850-22-000098:0
34,000 shares@ US$381.9212.5% of flowCommon StockSEC:0001883850-22-000092:0
40,000 shares@ US$555.6720.8% of flowCommon StockSEC:0001883850-22-000070:0
40,000 shares@ US$399.6614.7% of flowCommon StockSEC:0001708138-22-000018:0
697 shares@ US$664.340.4% of flowCommon StockSEC:0001883850-21-000029:0
4,344 shares0Common StockSEC:0001708138-21-000095:0
25,000 shares@ US$270.436.1% of flowCommon StockSEC:0001708138-21-000085:0
25,000 shares@ US$270.436.0% of flowCommon StockSEC:0001708138-21-000049:0
18 of 18 declarations
About Van Plew Daniel P
Van Plew Daniel P is Directeur Général and EVP & General Mgr, Industrial at Regeneron Pharmaceuticals, INC. The 18 filings in total span from 2021-08-10 to 2025-12-11, and across the sampled recent filings the sell volume is EUR 384497, with no purchases reported. The modal transaction nature is Levée d'options.
